Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer (Q40608630)
scientific article published on January 2001
Language:
(P31) (Q13442814)
(P50) (Q73567428)
(P304) 289-298
(P407) (Q1860)
(P433) 2
(P478) 19
(P577) Monday, January 1, 2001
(P921) (Q42824440)
(Q193447)
(P1433) (Q400292)
(P1476) "Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer" (language: en)
(P2093) J Nemunaitis
F Khuri
I Ganly
J Arseneau
M Posner
J Kuhn
T McCarty
S Landers
A Blackburn
L Romel
B Randlev
S Kaye
D Kirn
other details
description scientific article published on January 2001

External Links